nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—colon cancer—liver cancer	0.205	0.389	CtDrD
Fluorouracil—stomach cancer—liver cancer	0.166	0.316	CtDrD
Fluorouracil—MTHFR—liver cancer	0.166	0.75	CbGaD
Fluorouracil—pancreatic cancer—liver cancer	0.155	0.295	CtDrD
Fluorouracil—ALB—liver cancer	0.0555	0.25	CbGaD
Fluorouracil—ABCC4—Sorafenib—liver cancer	0.0427	0.297	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—liver cancer	0.0339	0.236	CbGbCtD
Fluorouracil—ABCG2—Sorafenib—liver cancer	0.023	0.16	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—liver cancer	0.0139	0.0969	CbGbCtD
Fluorouracil—CYP2C8—Sorafenib—liver cancer	0.0122	0.0851	CbGbCtD
Fluorouracil—CYP1A2—Sorafenib—liver cancer	0.00948	0.0659	CbGbCtD
Fluorouracil—CYP2C9—Sorafenib—liver cancer	0.00854	0.0594	CbGbCtD
Fluorouracil—ABCC3—bile duct—liver cancer	0.00357	0.303	CbGeAlD
Fluorouracil—Ocular toxicity—Epirubicin—liver cancer	0.00133	0.0319	CcSEcCtD
Fluorouracil—UPP2—liver—liver cancer	0.0013	0.11	CbGeAlD
Fluorouracil—Ocular toxicity—Doxorubicin—liver cancer	0.00123	0.0295	CcSEcCtD
Fluorouracil—Neutropenic sepsis—Epirubicin—liver cancer	0.00104	0.0249	CcSEcCtD
Fluorouracil—Neutropenic sepsis—Doxorubicin—liver cancer	0.000958	0.023	CcSEcCtD
Fluorouracil—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.000826	0.0198	CcSEcCtD
Fluorouracil—Cardiotoxicity—Epirubicin—liver cancer	0.000762	0.0183	CcSEcCtD
Fluorouracil—ABCC3—gall bladder—liver cancer	0.000762	0.0647	CbGeAlD
Fluorouracil—UMPS—liver—liver cancer	0.000736	0.0625	CbGeAlD
Fluorouracil—Proctitis—Epirubicin—liver cancer	0.000736	0.0177	CcSEcCtD
Fluorouracil—Cardiotoxicity—Doxorubicin—liver cancer	0.000705	0.0169	CcSEcCtD
Fluorouracil—Proctitis—Doxorubicin—liver cancer	0.000681	0.0163	CcSEcCtD
Fluorouracil—UPP1—liver—liver cancer	0.000675	0.0573	CbGeAlD
Fluorouracil—ALB—gall bladder—liver cancer	0.00065	0.0552	CbGeAlD
Fluorouracil—Myocardial ischaemia—Sorafenib—liver cancer	0.000604	0.0145	CcSEcCtD
Fluorouracil—Septic shock—Epirubicin—liver cancer	0.000595	0.0143	CcSEcCtD
Fluorouracil—Septic shock—Doxorubicin—liver cancer	0.00055	0.0132	CcSEcCtD
Fluorouracil—DPYD—liver—liver cancer	0.000548	0.0465	CbGeAlD
Fluorouracil—PPAT—liver—liver cancer	0.000474	0.0403	CbGeAlD
Fluorouracil—Pericarditis—Epirubicin—liver cancer	0.000415	0.00997	CcSEcCtD
Fluorouracil—Dysaesthesia—Epirubicin—liver cancer	0.000415	0.00997	CcSEcCtD
Fluorouracil—Pericarditis—Doxorubicin—liver cancer	0.000384	0.00922	CcSEcCtD
Fluorouracil—Dysaesthesia—Doxorubicin—liver cancer	0.000384	0.00922	CcSEcCtD
Fluorouracil—Myelosuppression—Epirubicin—liver cancer	0.000383	0.0092	CcSEcCtD
Fluorouracil—UMPS—Idarubicin—Epirubicin—liver cancer	0.000376	0.173	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—liver cancer	0.000376	0.173	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—liver cancer	0.000376	0.173	CbGdCrCtD
Fluorouracil—Cardiac failure—Sorafenib—liver cancer	0.000361	0.00868	CcSEcCtD
Fluorouracil—Myelosuppression—Doxorubicin—liver cancer	0.000354	0.00851	CcSEcCtD
Fluorouracil—Cardiomyopathy—Epirubicin—liver cancer	0.000351	0.00843	CcSEcCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—liver cancer	0.000348	0.16	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—liver cancer	0.000348	0.16	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—liver cancer	0.000348	0.16	CbGdCrCtD
Fluorouracil—Cardiomyopathy—Doxorubicin—liver cancer	0.000325	0.0078	CcSEcCtD
Fluorouracil—Local reaction—Epirubicin—liver cancer	0.000324	0.00779	CcSEcCtD
Fluorouracil—Dry skin—Sorafenib—liver cancer	0.000323	0.00776	CcSEcCtD
Fluorouracil—TYMP—liver—liver cancer	0.000317	0.027	CbGeAlD
Fluorouracil—SLC22A7—liver—liver cancer	0.000317	0.0269	CbGeAlD
Fluorouracil—Nasopharyngitis—Sorafenib—liver cancer	0.000315	0.00757	CcSEcCtD
Fluorouracil—Lacrimation—Epirubicin—liver cancer	0.000305	0.00733	CcSEcCtD
Fluorouracil—Dysphagia—Sorafenib—liver cancer	0.000305	0.00732	CcSEcCtD
Fluorouracil—Skin hyperpigmentation—Epirubicin—liver cancer	0.000302	0.00725	CcSEcCtD
Fluorouracil—Local reaction—Doxorubicin—liver cancer	0.0003	0.00721	CcSEcCtD
Fluorouracil—Febrile neutropenia—Epirubicin—liver cancer	0.000299	0.00717	CcSEcCtD
Fluorouracil—MTHFR—liver—liver cancer	0.000298	0.0254	CbGeAlD
Fluorouracil—Lacrimation—Doxorubicin—liver cancer	0.000283	0.00679	CcSEcCtD
Fluorouracil—Skin hyperpigmentation—Doxorubicin—liver cancer	0.000279	0.00671	CcSEcCtD
Fluorouracil—Nail disorder—Epirubicin—liver cancer	0.000277	0.00665	CcSEcCtD
Fluorouracil—Febrile neutropenia—Doxorubicin—liver cancer	0.000276	0.00663	CcSEcCtD
Fluorouracil—Pneumonia—Sorafenib—liver cancer	0.000273	0.00656	CcSEcCtD
Fluorouracil—TYMS—liver—liver cancer	0.000272	0.0231	CbGeAlD
Fluorouracil—Infestation—Sorafenib—liver cancer	0.000272	0.00653	CcSEcCtD
Fluorouracil—Infestation NOS—Sorafenib—liver cancer	0.000272	0.00653	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Sorafenib—liver cancer	0.000268	0.00643	CcSEcCtD
Fluorouracil—Myocardial infarction—Sorafenib—liver cancer	0.000266	0.0064	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Sorafenib—liver cancer	0.000266	0.0064	CcSEcCtD
Fluorouracil—ABCC5—liver—liver cancer	0.000266	0.0226	CbGeAlD
Fluorouracil—Stomatitis—Sorafenib—liver cancer	0.000265	0.00636	CcSEcCtD
Fluorouracil—Epistaxis—Sorafenib—liver cancer	0.000256	0.00616	CcSEcCtD
Fluorouracil—Nail disorder—Doxorubicin—liver cancer	0.000256	0.00615	CcSEcCtD
Fluorouracil—Nystagmus—Epirubicin—liver cancer	0.000251	0.00604	CcSEcCtD
Fluorouracil—Blister—Epirubicin—liver cancer	0.000249	0.00598	CcSEcCtD
Fluorouracil—Haemoglobin—Sorafenib—liver cancer	0.000245	0.00589	CcSEcCtD
Fluorouracil—SLC29A1—liver—liver cancer	0.000244	0.0207	CbGeAlD
Fluorouracil—Haemorrhage—Sorafenib—liver cancer	0.000244	0.00586	CcSEcCtD
Fluorouracil—CYP2A6—liver—liver cancer	0.000238	0.0203	CbGeAlD
Fluorouracil—Nystagmus—Doxorubicin—liver cancer	0.000233	0.00559	CcSEcCtD
Fluorouracil—Blister—Doxorubicin—liver cancer	0.000231	0.00554	CcSEcCtD
Fluorouracil—Necrosis—Epirubicin—liver cancer	0.000229	0.00549	CcSEcCtD
Fluorouracil—ABCC3—liver—liver cancer	0.000223	0.019	CbGeAlD
Fluorouracil—Stinging—Epirubicin—liver cancer	0.000222	0.00532	CcSEcCtD
Fluorouracil—Arrhythmia—Sorafenib—liver cancer	0.000218	0.00523	CcSEcCtD
Fluorouracil—Alopecia—Sorafenib—liver cancer	0.000216	0.00518	CcSEcCtD
Fluorouracil—Erythema—Sorafenib—liver cancer	0.000212	0.0051	CcSEcCtD
Fluorouracil—Necrosis—Doxorubicin—liver cancer	0.000212	0.00508	CcSEcCtD
Fluorouracil—Extravasation—Epirubicin—liver cancer	0.000206	0.00494	CcSEcCtD
Fluorouracil—Stinging—Doxorubicin—liver cancer	0.000205	0.00492	CcSEcCtD
Fluorouracil—Cellulitis—Epirubicin—liver cancer	0.000197	0.00474	CcSEcCtD
Fluorouracil—Anaemia—Sorafenib—liver cancer	0.000196	0.00471	CcSEcCtD
Fluorouracil—Lacrimation increased—Epirubicin—liver cancer	0.000195	0.00468	CcSEcCtD
Fluorouracil—Herpes simplex—Epirubicin—liver cancer	0.000195	0.00468	CcSEcCtD
Fluorouracil—ALB—liver—liver cancer	0.00019	0.0162	CbGeAlD
Fluorouracil—Extravasation—Doxorubicin—liver cancer	0.00019	0.00457	CcSEcCtD
Fluorouracil—Leukopenia—Sorafenib—liver cancer	0.00019	0.00457	CcSEcCtD
Fluorouracil—Dysarthria—Epirubicin—liver cancer	0.00019	0.00456	CcSEcCtD
Fluorouracil—Ulcer—Epirubicin—liver cancer	0.00019	0.00456	CcSEcCtD
Fluorouracil—Inflammation—Epirubicin—liver cancer	0.000185	0.00445	CcSEcCtD
Fluorouracil—ABCC4—liver—liver cancer	0.000184	0.0157	CbGeAlD
Fluorouracil—Cellulitis—Doxorubicin—liver cancer	0.000183	0.00439	CcSEcCtD
Fluorouracil—Myalgia—Sorafenib—liver cancer	0.000181	0.00434	CcSEcCtD
Fluorouracil—Lacrimation increased—Doxorubicin—liver cancer	0.00018	0.00433	CcSEcCtD
Fluorouracil—Herpes simplex—Doxorubicin—liver cancer	0.00018	0.00433	CcSEcCtD
Fluorouracil—Dermatitis contact—Epirubicin—liver cancer	0.000177	0.00426	CcSEcCtD
Fluorouracil—Dysarthria—Doxorubicin—liver cancer	0.000176	0.00422	CcSEcCtD
Fluorouracil—Ulcer—Doxorubicin—liver cancer	0.000176	0.00422	CcSEcCtD
Fluorouracil—Anaphylactic shock—Sorafenib—liver cancer	0.000173	0.00416	CcSEcCtD
Fluorouracil—Infection—Sorafenib—liver cancer	0.000172	0.00414	CcSEcCtD
Fluorouracil—Inflammation—Doxorubicin—liver cancer	0.000171	0.00411	CcSEcCtD
Fluorouracil—Nervous system disorder—Sorafenib—liver cancer	0.00017	0.00408	CcSEcCtD
Fluorouracil—Thrombocytopenia—Sorafenib—liver cancer	0.00017	0.00408	CcSEcCtD
Fluorouracil—Anorexia—Sorafenib—liver cancer	0.000165	0.00397	CcSEcCtD
Fluorouracil—Dermatitis contact—Doxorubicin—liver cancer	0.000164	0.00394	CcSEcCtD
Fluorouracil—Oesophagitis—Epirubicin—liver cancer	0.000164	0.00394	CcSEcCtD
Fluorouracil—Coma—Epirubicin—liver cancer	0.000164	0.00394	CcSEcCtD
Fluorouracil—Rash maculo-papular—Epirubicin—liver cancer	0.000163	0.00392	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000158	0.00379	CcSEcCtD
Fluorouracil—Sepsis—Epirubicin—liver cancer	0.000156	0.00374	CcSEcCtD
Fluorouracil—Dyspnoea—Sorafenib—liver cancer	0.000155	0.00371	CcSEcCtD
Fluorouracil—Dyspepsia—Sorafenib—liver cancer	0.000153	0.00366	CcSEcCtD
Fluorouracil—Oesophagitis—Doxorubicin—liver cancer	0.000152	0.00365	CcSEcCtD
Fluorouracil—Coma—Doxorubicin—liver cancer	0.000152	0.00365	CcSEcCtD
Fluorouracil—Rash maculo-papular—Doxorubicin—liver cancer	0.000151	0.00363	CcSEcCtD
Fluorouracil—Decreased appetite—Sorafenib—liver cancer	0.000151	0.00362	CcSEcCtD
Fluorouracil—Thrombophlebitis—Epirubicin—liver cancer	0.000151	0.00362	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Sorafenib—liver cancer	0.00015	0.00359	CcSEcCtD
Fluorouracil—Photosensitivity—Epirubicin—liver cancer	0.000148	0.00356	CcSEcCtD
Fluorouracil—Pain—Sorafenib—liver cancer	0.000148	0.00356	CcSEcCtD
Fluorouracil—Sepsis—Doxorubicin—liver cancer	0.000144	0.00346	CcSEcCtD
Fluorouracil—Thrombophlebitis—Doxorubicin—liver cancer	0.000139	0.00335	CcSEcCtD
Fluorouracil—Urticaria—Sorafenib—liver cancer	0.000138	0.00331	CcSEcCtD
Fluorouracil—Photosensitivity—Doxorubicin—liver cancer	0.000137	0.0033	CcSEcCtD
Fluorouracil—Body temperature increased—Sorafenib—liver cancer	0.000137	0.00329	CcSEcCtD
Fluorouracil—Dermatitis bullous—Epirubicin—liver cancer	0.000136	0.00327	CcSEcCtD
Fluorouracil—CYP2C8—liver—liver cancer	0.000134	0.0114	CbGeAlD
Fluorouracil—Cardiac failure—Epirubicin—liver cancer	0.000134	0.00321	CcSEcCtD
Fluorouracil—Lethargy—Epirubicin—liver cancer	0.000133	0.00319	CcSEcCtD
Fluorouracil—Osteoarthritis—Epirubicin—liver cancer	0.00013	0.00313	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00013	0.00313	CcSEcCtD
Fluorouracil—ABCG2—liver—liver cancer	0.00013	0.0111	CbGeAlD
Fluorouracil—Hypersensitivity—Sorafenib—liver cancer	0.000128	0.00307	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—liver cancer	0.000126	0.00303	CcSEcCtD
Fluorouracil—CYP1A2—liver—liver cancer	0.000125	0.0106	CbGeAlD
Fluorouracil—Cardiac arrest—Epirubicin—liver cancer	0.000124	0.00298	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—liver cancer	0.000124	0.00297	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—liver cancer	0.000123	0.00296	CcSEcCtD
Fluorouracil—Pruritus—Sorafenib—liver cancer	0.000123	0.00295	CcSEcCtD
Fluorouracil—Ataxia—Epirubicin—liver cancer	0.000123	0.00294	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000121	0.0029	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—liver cancer	0.000121	0.0029	CcSEcCtD
Fluorouracil—Dry skin—Epirubicin—liver cancer	0.000119	0.00287	CcSEcCtD
Fluorouracil—CYP2C9—liver—liver cancer	0.000119	0.0101	CbGeAlD
Fluorouracil—Diarrhoea—Sorafenib—liver cancer	0.000119	0.00285	CcSEcCtD
Fluorouracil—Nasopharyngitis—Epirubicin—liver cancer	0.000117	0.0028	CcSEcCtD
Fluorouracil—Muscular weakness—Epirubicin—liver cancer	0.000115	0.00276	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—liver cancer	0.000115	0.00275	CcSEcCtD
Fluorouracil—Dizziness—Sorafenib—liver cancer	0.000115	0.00275	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—liver cancer	0.000113	0.00272	CcSEcCtD
Fluorouracil—Dysphagia—Epirubicin—liver cancer	0.000113	0.00271	CcSEcCtD
Fluorouracil—Eosinophilia—Epirubicin—liver cancer	0.000112	0.00268	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—liver cancer	0.000111	0.00265	CcSEcCtD
Fluorouracil—Vomiting—Sorafenib—liver cancer	0.00011	0.00265	CcSEcCtD
Fluorouracil—Angina pectoris—Epirubicin—liver cancer	0.00011	0.00264	CcSEcCtD
Fluorouracil—Rash—Sorafenib—liver cancer	0.000109	0.00262	CcSEcCtD
Fluorouracil—Dermatitis—Sorafenib—liver cancer	0.000109	0.00262	CcSEcCtD
Fluorouracil—Headache—Sorafenib—liver cancer	0.000109	0.00261	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—liver cancer	0.000108	0.00259	CcSEcCtD
Fluorouracil—Pancytopenia—Epirubicin—liver cancer	0.000107	0.00257	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—liver cancer	0.000106	0.00255	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Epirubicin—liver cancer	0.000105	0.00251	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—liver cancer	0.000104	0.0025	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—liver cancer	0.000103	0.00248	CcSEcCtD
Fluorouracil—Nausea—Sorafenib—liver cancer	0.000103	0.00247	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Epirubicin—liver cancer	0.000103	0.00247	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—liver cancer	0.000102	0.00244	CcSEcCtD
Fluorouracil—Pneumonia—Epirubicin—liver cancer	0.000101	0.00243	CcSEcCtD
Fluorouracil—Infestation NOS—Epirubicin—liver cancer	0.0001	0.00241	CcSEcCtD
Fluorouracil—Infestation—Epirubicin—liver cancer	0.0001	0.00241	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—liver cancer	9.9e-05	0.00238	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Epirubicin—liver cancer	9.85e-05	0.00236	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—liver cancer	9.79e-05	0.00235	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—liver cancer	9.76e-05	0.00234	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—liver cancer	9.76e-05	0.00234	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—liver cancer	9.69e-05	0.00233	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—liver cancer	9.52e-05	0.00228	CcSEcCtD
Fluorouracil—Epistaxis—Epirubicin—liver cancer	9.48e-05	0.00228	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—liver cancer	9.42e-05	0.00226	CcSEcCtD
Fluorouracil—Agranulocytosis—Epirubicin—liver cancer	9.37e-05	0.00225	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—liver cancer	9.35e-05	0.00224	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—liver cancer	9.3e-05	0.00223	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—liver cancer	9.3e-05	0.00223	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—liver cancer	9.11e-05	0.00219	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—liver cancer	9.06e-05	0.00218	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—liver cancer	9.06e-05	0.00218	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—liver cancer	9.04e-05	0.00217	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—liver cancer	9.04e-05	0.00217	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—liver cancer	9.04e-05	0.00217	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—liver cancer	9.02e-05	0.00217	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—liver cancer	8.97e-05	0.00215	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—liver cancer	8.95e-05	0.00215	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—liver cancer	8.77e-05	0.00211	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—liver cancer	8.72e-05	0.00209	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—liver cancer	8.67e-05	0.00208	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—liver cancer	8.39e-05	0.00201	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—liver cancer	8.37e-05	0.00201	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—liver cancer	8.34e-05	0.002	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—liver cancer	8.3e-05	0.00199	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—liver cancer	8.28e-05	0.00199	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—liver cancer	8.06e-05	0.00193	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—liver cancer	7.97e-05	0.00191	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—liver cancer	7.85e-05	0.00188	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—liver cancer	7.45e-05	0.00179	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—liver cancer	7.4e-05	0.00178	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—liver cancer	7.37e-05	0.00177	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—liver cancer	7.26e-05	0.00174	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—liver cancer	7.26e-05	0.00174	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—liver cancer	7.03e-05	0.00169	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—liver cancer	6.85e-05	0.00164	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—liver cancer	6.8e-05	0.00163	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—liver cancer	6.71e-05	0.00161	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—liver cancer	6.68e-05	0.0016	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—liver cancer	6.68e-05	0.0016	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—liver cancer	6.6e-05	0.00159	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—liver cancer	6.5e-05	0.00156	CcSEcCtD
Fluorouracil—Confusional state—Epirubicin—liver cancer	6.46e-05	0.00155	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—liver cancer	6.41e-05	0.00154	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—liver cancer	6.41e-05	0.00154	CcSEcCtD
Fluorouracil—Infection—Epirubicin—liver cancer	6.37e-05	0.00153	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—liver cancer	6.29e-05	0.00151	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—liver cancer	6.28e-05	0.00151	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—liver cancer	6.27e-05	0.00151	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—liver cancer	6.25e-05	0.0015	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—liver cancer	6.18e-05	0.00148	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—liver cancer	6.18e-05	0.00148	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—liver cancer	6.11e-05	0.00147	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—liver cancer	6.11e-05	0.00147	CcSEcCtD
Fluorouracil—Hypotension—Epirubicin—liver cancer	5.99e-05	0.00144	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—liver cancer	5.98e-05	0.00144	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—liver cancer	5.93e-05	0.00142	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—liver cancer	5.93e-05	0.00142	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—liver cancer	5.89e-05	0.00141	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—liver cancer	5.84e-05	0.0014	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—liver cancer	5.81e-05	0.0014	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—liver cancer	5.8e-05	0.00139	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—liver cancer	5.79e-05	0.00139	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—liver cancer	5.79e-05	0.00139	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—liver cancer	5.75e-05	0.00138	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—liver cancer	5.71e-05	0.00137	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—liver cancer	5.7e-05	0.00137	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—liver cancer	5.65e-05	0.00136	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—liver cancer	5.64e-05	0.00135	CcSEcCtD
Fluorouracil—Decreased appetite—Epirubicin—liver cancer	5.57e-05	0.00134	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—liver cancer	5.54e-05	0.00133	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—liver cancer	5.53e-05	0.00133	CcSEcCtD
Fluorouracil—Pain—Epirubicin—liver cancer	5.48e-05	0.00132	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—liver cancer	5.4e-05	0.0013	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—liver cancer	5.36e-05	0.00129	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—liver cancer	5.32e-05	0.00128	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—liver cancer	5.29e-05	0.00127	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—liver cancer	5.28e-05	0.00127	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—liver cancer	5.27e-05	0.00127	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—liver cancer	5.22e-05	0.00125	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—liver cancer	5.15e-05	0.00124	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—liver cancer	5.12e-05	0.00123	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—liver cancer	5.09e-05	0.00122	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—liver cancer	5.07e-05	0.00122	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—liver cancer	5.06e-05	0.00122	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—liver cancer	4.89e-05	0.00117	CcSEcCtD
Fluorouracil—Hypersensitivity—Epirubicin—liver cancer	4.72e-05	0.00113	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—liver cancer	4.71e-05	0.00113	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—liver cancer	4.69e-05	0.00113	CcSEcCtD
Fluorouracil—Pruritus—Epirubicin—liver cancer	4.53e-05	0.00109	CcSEcCtD
Fluorouracil—Diarrhoea—Epirubicin—liver cancer	4.38e-05	0.00105	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—liver cancer	4.37e-05	0.00105	CcSEcCtD
Fluorouracil—Dizziness—Epirubicin—liver cancer	4.24e-05	0.00102	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—liver cancer	4.19e-05	0.00101	CcSEcCtD
Fluorouracil—Vomiting—Epirubicin—liver cancer	4.07e-05	0.000978	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—liver cancer	4.06e-05	0.000974	CcSEcCtD
Fluorouracil—Rash—Epirubicin—liver cancer	4.04e-05	0.00097	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—liver cancer	4.04e-05	0.000969	CcSEcCtD
Fluorouracil—Headache—Epirubicin—liver cancer	4.01e-05	0.000964	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—liver cancer	3.92e-05	0.000941	CcSEcCtD
Fluorouracil—Nausea—Epirubicin—liver cancer	3.81e-05	0.000914	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—liver cancer	3.77e-05	0.000905	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—liver cancer	3.74e-05	0.000897	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—liver cancer	3.73e-05	0.000897	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—liver cancer	3.71e-05	0.000892	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—liver cancer	3.52e-05	0.000845	CcSEcCtD
Fluorouracil—CYP2A6—Metabolism—PSMA4—liver cancer	5.29e-06	0.000101	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PSMD10—liver cancer	5.29e-06	0.000101	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTA2—liver cancer	5.29e-06	0.000101	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CG—liver cancer	5.25e-06	0.000101	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CB—liver cancer	5.19e-06	9.94e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CD—liver cancer	5.18e-06	9.93e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—MTHFR—liver cancer	5.17e-06	9.91e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GOT2—liver cancer	5.15e-06	9.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTA1—liver cancer	5.13e-06	9.82e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—liver cancer	5.12e-06	9.81e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CPT1B—liver cancer	5.12e-06	9.81e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GLUL—liver cancer	5.12e-06	9.81e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ALB—liver cancer	5.12e-06	9.8e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTA1—liver cancer	5.1e-06	9.77e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPARA—liver cancer	5.08e-06	9.72e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NAT2—liver cancer	5.07e-06	9.71e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PPARG—liver cancer	5.07e-06	9.71e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN1B—liver cancer	5.06e-06	9.7e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NAT2—liver cancer	5.04e-06	9.66e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	5.02e-06	9.62e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYCS—liver cancer	4.98e-06	9.54e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NR1H4—liver cancer	4.94e-06	9.46e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK14—liver cancer	4.92e-06	9.42e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GGT1—liver cancer	4.89e-06	9.36e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GOT1—liver cancer	4.89e-06	9.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.88e-06	9.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALDOB—liver cancer	4.86e-06	9.31e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	4.86e-06	9.3e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTA3—liver cancer	4.85e-06	9.3e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.85e-06	9.29e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP2E1—liver cancer	4.84e-06	9.27e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ALDOB—liver cancer	4.83e-06	9.26e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PIK3CA—liver cancer	4.79e-06	9.18e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—STAT3—liver cancer	4.79e-06	9.17e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CTNNB1—liver cancer	4.78e-06	9.16e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—F2—liver cancer	4.77e-06	9.13e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.74e-06	9.08e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PIK3CA—liver cancer	4.71e-06	9.02e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN1A—liver cancer	4.67e-06	8.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CRABP1—liver cancer	4.64e-06	8.88e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CD—liver cancer	4.62e-06	8.84e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CRABP1—liver cancer	4.61e-06	8.83e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	4.61e-06	8.83e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CG—liver cancer	4.56e-06	8.74e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.56e-06	8.73e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ALB—liver cancer	4.56e-06	8.73e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—liver cancer	4.55e-06	8.72e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYCS—liver cancer	4.53e-06	8.67e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CB—liver cancer	4.52e-06	8.65e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—liver cancer	4.45e-06	8.52e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GGT1—liver cancer	4.44e-06	8.51e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GOT1—liver cancer	4.44e-06	8.51e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTA4—liver cancer	4.44e-06	8.5e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—liver cancer	4.44e-06	8.5e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTP1—liver cancer	4.39e-06	8.41e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CPT1B—liver cancer	4.38e-06	8.38e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GLUL—liver cancer	4.38e-06	8.38e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—liver cancer	4.36e-06	8.34e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CG—liver cancer	4.35e-06	8.32e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.34e-06	8.31e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—HMOX1—liver cancer	4.33e-06	8.3e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTA2—liver cancer	4.33e-06	8.29e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NR1H4—liver cancer	4.22e-06	8.08e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPARG—liver cancer	4.19e-06	8.03e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.18e-06	8e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTA1—liver cancer	4.17e-06	7.99e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—liver cancer	4.17e-06	7.98e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.15e-06	7.95e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTA3—liver cancer	4.15e-06	7.94e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	4.13e-06	7.92e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NAT2—liver cancer	4.13e-06	7.9e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—liver cancer	4.11e-06	7.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HPGDS—liver cancer	4.05e-06	7.76e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTM1—liver cancer	4.04e-06	7.73e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HPGDS—liver cancer	4.03e-06	7.72e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.03e-06	7.72e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CB—liver cancer	4.02e-06	7.71e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CD—liver cancer	4.01e-06	7.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.01e-06	7.68e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTP1—liver cancer	3.99e-06	7.64e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.97e-06	7.6e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SERPINE1—liver cancer	3.97e-06	7.6e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALDOB—liver cancer	3.96e-06	7.58e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—HMOX1—liver cancer	3.94e-06	7.54e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—liver cancer	3.92e-06	7.5e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—liver cancer	3.87e-06	7.42e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—liver cancer	3.86e-06	7.4e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—liver cancer	3.85e-06	7.37e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP1A1—liver cancer	3.83e-06	7.33e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CD—liver cancer	3.82e-06	7.32e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTA4—liver cancer	3.79e-06	7.27e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—liver cancer	3.78e-06	7.23e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CRABP1—liver cancer	3.77e-06	7.23e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALB—liver cancer	3.77e-06	7.22e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.71e-06	7.1e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTA2—liver cancer	3.7e-06	7.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.67e-06	7.03e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTM1—liver cancer	3.67e-06	7.02e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.65e-06	6.99e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.62e-06	6.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PSMA4—liver cancer	3.61e-06	6.92e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PSMD10—liver cancer	3.61e-06	6.92e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PSMD10—liver cancer	3.59e-06	6.88e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PSMA4—liver cancer	3.59e-06	6.88e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—RAF1—liver cancer	3.58e-06	6.86e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—liver cancer	3.58e-06	6.86e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTA1—liver cancer	3.57e-06	6.83e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MTHFR—liver cancer	3.57e-06	6.83e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NAT2—liver cancer	3.53e-06	6.76e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GOT2—liver cancer	3.52e-06	6.73e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARA—liver cancer	3.5e-06	6.7e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GOT2—liver cancer	3.5e-06	6.69e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CB—liver cancer	3.49e-06	6.69e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—liver cancer	3.49e-06	6.69e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP1A1—liver cancer	3.48e-06	6.66e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.4e-06	6.51e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.39e-06	6.5e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALDOB—liver cancer	3.38e-06	6.48e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.38e-06	6.47e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—liver cancer	3.34e-06	6.41e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CB—liver cancer	3.33e-06	6.38e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2E1—liver cancer	3.3e-06	6.33e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HPGDS—liver cancer	3.3e-06	6.32e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—liver cancer	3.29e-06	6.3e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2E1—liver cancer	3.29e-06	6.29e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.28e-06	6.28e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MTHFR—liver cancer	3.24e-06	6.21e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CRABP1—liver cancer	3.23e-06	6.18e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—liver cancer	3.21e-06	6.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.2e-06	6.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.18e-06	6.09e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARA—liver cancer	3.18e-06	6.09e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—liver cancer	3.16e-06	6.06e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	3.1e-06	5.93e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYCS—liver cancer	3.09e-06	5.92e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—liver cancer	3.09e-06	5.91e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYCS—liver cancer	3.07e-06	5.89e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—liver cancer	3.04e-06	5.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GGT1—liver cancer	3.03e-06	5.81e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GOT1—liver cancer	3.03e-06	5.81e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GGT1—liver cancer	3.02e-06	5.78e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GOT1—liver cancer	3.02e-06	5.78e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—liver cancer	3e-06	5.74e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.99e-06	5.72e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.95e-06	5.65e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PSMA4—liver cancer	2.94e-06	5.63e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PSMD10—liver cancer	2.94e-06	5.63e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—liver cancer	2.91e-06	5.58e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.9e-06	5.56e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARG—liver cancer	2.89e-06	5.54e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GOT2—liver cancer	2.86e-06	5.48e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HPGDS—liver cancer	2.82e-06	5.4e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.8e-06	5.37e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—liver cancer	2.75e-06	5.27e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—liver cancer	2.73e-06	5.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—liver cancer	2.73e-06	5.22e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—liver cancer	2.72e-06	5.21e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—liver cancer	2.71e-06	5.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2E1—liver cancer	2.69e-06	5.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HMOX1—liver cancer	2.69e-06	5.15e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—liver cancer	2.69e-06	5.15e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HMOX1—liver cancer	2.67e-06	5.12e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CD—liver cancer	2.63e-06	5.05e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARG—liver cancer	2.63e-06	5.03e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.6e-06	4.99e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—liver cancer	2.6e-06	4.98e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—liver cancer	2.58e-06	4.95e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.55e-06	4.89e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.52e-06	4.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYCS—liver cancer	2.52e-06	4.82e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PSMD10—liver cancer	2.51e-06	4.81e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PSMA4—liver cancer	2.51e-06	4.81e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTM1—liver cancer	2.5e-06	4.8e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—liver cancer	2.5e-06	4.79e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTM1—liver cancer	2.49e-06	4.77e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GGT1—liver cancer	2.47e-06	4.73e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GOT1—liver cancer	2.47e-06	4.73e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—liver cancer	2.45e-06	4.7e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GOT2—liver cancer	2.44e-06	4.68e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CD—liver cancer	2.39e-06	4.58e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1A1—liver cancer	2.37e-06	4.55e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—liver cancer	2.36e-06	4.53e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1A1—liver cancer	2.36e-06	4.52e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—liver cancer	2.32e-06	4.44e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2E1—liver cancer	2.3e-06	4.4e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CB—liver cancer	2.3e-06	4.4e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—liver cancer	2.25e-06	4.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.23e-06	4.26e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—liver cancer	2.22e-06	4.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTHFR—liver cancer	2.21e-06	4.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTHFR—liver cancer	2.2e-06	4.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HMOX1—liver cancer	2.19e-06	4.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARA—liver cancer	2.17e-06	4.16e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARA—liver cancer	2.16e-06	4.14e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYCS—liver cancer	2.15e-06	4.12e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—liver cancer	2.13e-06	4.08e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GGT1—liver cancer	2.11e-06	4.04e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GOT1—liver cancer	2.11e-06	4.04e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CB—liver cancer	2.09e-06	4e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—liver cancer	2.06e-06	3.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTM1—liver cancer	2.04e-06	3.9e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—liver cancer	2.03e-06	3.89e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—liver cancer	2e-06	3.84e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—liver cancer	1.97e-06	3.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.95e-06	3.74e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.94e-06	3.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1A1—liver cancer	1.93e-06	3.7e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—liver cancer	1.9e-06	3.63e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HMOX1—liver cancer	1.87e-06	3.58e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—liver cancer	1.86e-06	3.56e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—liver cancer	1.85e-06	3.54e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTHFR—liver cancer	1.8e-06	3.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARG—liver cancer	1.79e-06	3.44e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARG—liver cancer	1.78e-06	3.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARA—liver cancer	1.77e-06	3.39e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTM1—liver cancer	1.74e-06	3.34e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—liver cancer	1.74e-06	3.33e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—liver cancer	1.66e-06	3.18e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1A1—liver cancer	1.65e-06	3.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CD—liver cancer	1.63e-06	3.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CD—liver cancer	1.63e-06	3.11e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—liver cancer	1.61e-06	3.09e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.59e-06	3.04e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTHFR—liver cancer	1.54e-06	2.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—liver cancer	1.51e-06	2.9e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARA—liver cancer	1.51e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARG—liver cancer	1.46e-06	2.8e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CB—liver cancer	1.43e-06	2.73e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CB—liver cancer	1.42e-06	2.71e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—liver cancer	1.4e-06	2.68e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.36e-06	2.6e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CD—liver cancer	1.33e-06	2.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—liver cancer	1.31e-06	2.52e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—liver cancer	1.29e-06	2.48e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—liver cancer	1.27e-06	2.44e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARG—liver cancer	1.25e-06	2.39e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CB—liver cancer	1.16e-06	2.22e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—liver cancer	1.14e-06	2.19e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CD—liver cancer	1.14e-06	2.18e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—liver cancer	1.12e-06	2.15e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—liver cancer	1.04e-06	1.99e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CB—liver cancer	9.91e-07	1.9e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—liver cancer	8.69e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—liver cancer	8.64e-07	1.65e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—liver cancer	7.1e-07	1.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—liver cancer	7.07e-07	1.35e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—liver cancer	7.06e-07	1.35e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—liver cancer	6.04e-07	1.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—liver cancer	5.78e-07	1.11e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—liver cancer	4.94e-07	9.45e-06	CbGpPWpGaD
